Yasaman Iranmanesh

Long-term outcomes and treatment cessation in patients with long term response to first line treatment of metastatic prostate cancer

Abstract Background and objective Approximately one third of men with metastatic prostate cancer die from causes other than prostate cancer. Little is known about the long-term outcomes of men with metastatic prostate cancer, in particular those who do not develop androgen pathwa...